Sales of Alnylam's first drug beat expectations in final quarter of 2018

The announcement commanded investor's attention to kick off the weeklong JP Morgan Healthcare conference.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.